Advertisement
Screener

Krystal Biotech, Inc. (KRYS) State and Local Income Tax Expense (Benefit), Continuing Operations

3.5 / 5 stars · 35/50 Roast Me

Krystal Biotech, Inc. State and Local Income Tax Expense (Benefit), Continuing Operations

Krystal Biotech, Inc. (KRYS) reported State and Local Income Tax Expense (Benefit), Continuing Operations of $1.07 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.

Financial Statements › Expense Statement › Income Tax

us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations · last filed 2026-02-17

  • Krystal Biotech, Inc. state and local income tax expense (benefit), continuing operations for fiscal 2025 was $1.07M, a 76.76% decline from fiscal 2024.
  • Krystal Biotech, Inc. state and local income tax expense (benefit), continuing operations for fiscal 2024 was $4.60M, a 170.21% increase from fiscal 2023.
  • Krystal Biotech, Inc. state and local income tax expense (benefit), continuing operations for fiscal 2023 was $1.70M.
  • Krystal Biotech, Inc. state and local income tax expense (benefit), continuing operations for fiscal 2022 was $0.00.
Period endState and Local Income Tax Expense (Benefit), Continuing Operations 12 month
2025-12-31$1.07M
10-K · filed 2026-02-17
2024-12-31$4.60M
10-K · filed 2026-02-17
2023-12-31$1.70M
10-K · filed 2026-02-17
2022-12-31$0.00
10-K · filed 2025-02-19
2021-12-31$0.00
10-K · filed 2024-02-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
REPLIGEN CORP (RGEN)United States$10.755B185.31
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
BIO-TECHNE Corp (TECH)United States$11.379B74.68
Twist Bioscience Corp (TWST)United States$11.540B-47.21
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Immunovant, Inc. (IMVT)United States$7.028B-14.78
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
CG Oncology, Inc. (CGON)United States$6.095B-27.95